Elevated levels of IL-1β have also been detected in patients affected by memory deficits such as mild cognitive impairment and Alzheimer’s disease (AD), thus suggesting that IL-1β overproduction may be an early factor concurring to AD pathogenesis and progression [5, 6]. This evidence concerns the gene IL1B and Cognitive impairment.